Free Trial

Tenet Healthcare (NYSE:THC) Receives Overweight Rating from Cantor Fitzgerald

Tenet Healthcare logo with Medical background

Tenet Healthcare (NYSE:THC - Get Free Report)'s stock had its "overweight" rating reaffirmed by investment analysts at Cantor Fitzgerald in a research note issued on Thursday,Benzinga reports. They currently have a $177.00 price target on the stock. Cantor Fitzgerald's target price indicates a potential upside of 32.68% from the stock's previous close.

THC has been the subject of several other research reports. Raymond James downgraded shares of Tenet Healthcare from a "strong-buy" rating to an "outperform" rating and set a $195.00 price target for the company. in a research note on Friday, November 22nd. Wells Fargo & Company cut Tenet Healthcare from an "overweight" rating to an "equal weight" rating and decreased their price objective for the company from $205.00 to $150.00 in a research note on Monday, November 25th. StockNews.com lowered shares of Tenet Healthcare from a "strong-buy" rating to a "buy" rating in a research note on Tuesday, December 17th. Royal Bank of Canada lifted their price target on shares of Tenet Healthcare from $174.00 to $183.00 and gave the stock an "outperform" rating in a research note on Wednesday, October 30th. Finally, Barclays dropped their price objective on shares of Tenet Healthcare from $190.00 to $161.00 and set an "overweight" rating on the stock in a research report on Thursday. Four equities research analysts have rated the stock with a hold rating, thirteen have issued a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and a consensus price target of $163.19.

Read Our Latest Stock Analysis on THC

Tenet Healthcare Trading Down 0.1 %

NYSE:THC traded down $0.17 on Thursday, reaching $133.40. The company's stock had a trading volume of 1,991,865 shares, compared to its average volume of 951,949. The firm has a market cap of $12.69 billion, a price-to-earnings ratio of 4.27, a price-to-earnings-growth ratio of 0.63 and a beta of 2.05. The company has a quick ratio of 1.52, a current ratio of 1.58 and a debt-to-equity ratio of 2.35. Tenet Healthcare has a 12-month low of $88.57 and a 12-month high of $171.20. The stock has a 50 day moving average price of $133.32 and a 200 day moving average price of $148.10.

Tenet Healthcare (NYSE:THC - Get Free Report) last posted its earnings results on Wednesday, February 12th. The company reported $3.44 EPS for the quarter, beating analysts' consensus estimates of $2.95 by $0.49. Tenet Healthcare had a net margin of 14.91% and a return on equity of 24.05%. On average, equities analysts anticipate that Tenet Healthcare will post 11.37 EPS for the current fiscal year.

Institutional Trading of Tenet Healthcare

Several hedge funds have recently modified their holdings of the business. Plato Investment Management Ltd acquired a new stake in Tenet Healthcare in the third quarter valued at $28,000. Colonial Trust Co SC increased its stake in shares of Tenet Healthcare by 85.7% during the 4th quarter. Colonial Trust Co SC now owns 247 shares of the company's stock worth $31,000 after purchasing an additional 114 shares in the last quarter. Financial Management Professionals Inc. grew its holdings in Tenet Healthcare by 2,222.2% during the 3rd quarter. Financial Management Professionals Inc. now owns 209 shares of the company's stock valued at $35,000 after buying an additional 200 shares during the last quarter. GeoWealth Management LLC raised its stake in Tenet Healthcare by 39.8% in the 4th quarter. GeoWealth Management LLC now owns 295 shares of the company's stock valued at $37,000 after purchasing an additional 84 shares during the last quarter. Finally, True Wealth Design LLC acquired a new position in Tenet Healthcare in the 3rd quarter valued at $38,000. 95.44% of the stock is owned by institutional investors and hedge funds.

About Tenet Healthcare

(Get Free Report)

Tenet Healthcare Corporation operates as a diversified healthcare services company in the United States. The company operates through two segments: Hospital Operations and Services, and Ambulatory Care. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies.

Featured Stories

Analyst Recommendations for Tenet Healthcare (NYSE:THC)

Should You Invest $1,000 in Tenet Healthcare Right Now?

Before you consider Tenet Healthcare, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Tenet Healthcare wasn't on the list.

While Tenet Healthcare currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

NVIDIA Earnings: Will it Spark a Rally or Trigger a Sell-Off?
Marjorie Taylor Greene Bought THOUSANDS in Tesla Stock
The EXACT Date of Next Stock Market Crash

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines